Fdc Limited (FDC)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
245.7
-1.45(-0.59%)

FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

249.7

TODAY'S LOW

245

52 WEEK HIGH

404.9

52 WEEK LOW

243

Major Holders

% of Shares Held by
All Insider

69.54%

% of Shares Held by
Institutions

8.30%

% of Float Held by
Institutions

27.24%

Number of Institutions
Holding Shares

23

Company Overview

MARKET CAP

4076.40 Cr.

ETERPRISE VALUE

3609.80 Cr.

NO. OF SHARES

16.59 Cr.

BOOK VALUE

112.817

DIV. YIELD

0.8%

DEBT

10.89 Cr.

GROSS PROFIT

896.22 Cr.

CASH

618.74 Cr.

REVENUE

1500.26 Cr.

REVENUE/SHARE

88.687

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments-27.78 Cr.-135.73 Cr.-94.12 Cr.23.01 Cr.
Change To Liabilities-45.65 Cr.51.73 Cr.-26.96 Cr.26.68 Cr.
Total cashflows from Investing Activities-77.15 Cr.-98.35 Cr.-120.32 Cr.20.10 Cr.
Net Borrowings-9.81 Cr.-6.09 Cr.-9.03 Lakhs-9.15 Lakhs
Total Cash from Financing Activities-129.34 Cr.-141.99 Cr.-6.64 Lakhs-169.43 Cr.
Other Liabilities-1.20 Cr.11.71 Cr.-3.89 Cr.-21.23 Cr.
Total Assets0000
Net Income301.34 Cr.239.87 Cr.169.78 Cr.173.50 Cr.
Change in Cash55.46 Lakhs9.96 Cr.-8.21 Cr.1.02 Cr.
Effect of Exchange Rate-2.43 Lakhs-7.06 Lakhs-25 Lakhs50.59 Lakhs
Total Cash from Operating Activities207.08 Cr.250.38 Cr.112.42 Cr.149.84 Cr.
Depreciation35.99 Cr.35.69 Cr.31.54 Cr.33.42 Cr.
Other Cashflows from Investing Activities9.43 Cr.41.10 Cr.16 Cr.33.07 Cr.
Dividends Paid0-13.67 Cr.-13.67 Cr.-40.01 Cr.
Change to Inventory-4.96 Cr.-36.17 Cr.-13.30 Cr.-23.32 Cr.
Change to Account Receivables12.40 Cr.-35.04 Cr.-6.89 Cr.-5.35 Cr.
Other Cashflows from Financing Activities-22.19 Cr.-2.17 Cr.2.39 Lakhs-9.27 Cr.
Change to Net Income-92.65 Cr.-19.18 Cr.-39.54 Cr.-35.56 Cr.
Capital Expenditures-62.53 Cr.-31.23 Cr.-42.72 Cr.-37.01 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax387.72 Cr.319.95 Cr.236.63 Cr.240.63 Cr.
Minority Interest-17.32 Lakhs-17.32 Lakhs-17.32 Lakhs-17.32 Lakhs
Net Income296.24 Cr.267.26 Cr.197.77 Cr.197.90 Cr.
Selling General Administrative335.25 Cr.334.36 Cr.277.24 Cr.267.72 Cr.
Gross Profit896.22 Cr.897.28 Cr.721.01 Cr.703.08 Cr.
Ebit296.24 Cr.267.26 Cr.197.77 Cr.197.90 Cr.
Operating Income296.24 Cr.267.26 Cr.197.77 Cr.197.90 Cr.
Other Operating Expenses226.91 Cr.258.26 Cr.212.82 Cr.202.39 Cr.
Interest Expense-2.76 Cr.-3.01 Cr.-1.08 Cr.-1.08 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense86.52 Cr.80.07 Cr.66.84 Cr.67.12 Cr.
Total Revenue1333.20 Cr.1344.19 Cr.1090.69 Cr.1075.06 Cr.
Total Operating Expenses1036.95 Cr.1076.92 Cr.892.92 Cr.877.16 Cr.
Cost of Revenue436.97 Cr.446.90 Cr.369.68 Cr.371.98 Cr.
Total Other Income Expense Net91.48 Cr.52.68 Cr.38.86 Cr.42.73 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.301.19 Cr.239.87 Cr.169.78 Cr.173.50 Cr.
Net Income Applicable to Common Shares301.34 Cr.239.87 Cr.169.78 Cr.173.50 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets4.39 Cr.6.21 Cr.6.43 Cr.8.08 Cr.
Capital Surplus0000
Total Liabilities222.27 Cr.265.49 Cr.194.64 Cr.229.10 Cr.
Stock Holder Equity1734.13 Cr.1547.42 Cr.1445.23 Cr.1276.11 Cr.
Minority Interest-17.32 Lakhs000
Other Liabilities59.72 Cr.62.56 Cr.54.45 Cr.57.92 Cr.
Total Assets1956.23 Cr.1812.92 Cr.1639.88 Cr.1505.21 Cr.
Common Stock16.88 Cr.17.09 Cr.17.44 Cr.17.44 Cr.
Retained Earnings1711.46 Cr.1527.51 Cr.1424.81 Cr.1255.41 Cr.
Other Liabilities11.26 Cr.9.53 Cr.15.10 Cr.17.04 Cr.
Good Will0000
Treasury Stock5.78 Cr.2.81 Cr.2.97 Cr.3.25 Cr.
Other Assets48.76 Cr.26.13 Cr.26.21 Cr.22.32 Cr.
Cash30.43 Cr.29.87 Cr.19.91 Cr.28.12 Cr.
Current Liabilities203.99 Cr.246.33 Cr.179.05 Cr.211.45 Cr.
Long Term Asset Charges0000
Short Long Term Debt13.57 Lakhs14.65 Lakhs11.44 Lakhs9.03 Lakhs
Other Stockholder Equity5.78 Cr.2.81 Cr.2.97 Cr.3.25 Cr.
Property Plant Equipment703.96 Cr.691.13 Cr.688.12 Cr.678.40 Cr.
Total Cur. Assets933.74 Cr.927.13 Cr.739.99 Cr.722.32 Cr.
Long Term Investments265.35 Cr.162.31 Cr.179.10 Cr.74.07 Cr.
Net Tangible Assets1729.74 Cr.1541.21 Cr.1438.79 Cr.1268.02 Cr.
Short Term Investments0000
Net Receivables118.19 Cr.144.31 Cr.93.48 Cr.91 Cr.
Long Term Debt20.80 Lakhs34.36 Lakhs49.01 Lakhs60.45 Lakhs
Inventory214.92 Cr.209.96 Cr.173.78 Cr.160.48 Cr.
Accounts Payable77.27 Cr.117.85 Cr.77.61 Cr.97.31 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account